Andina Acquisition Corp. III ANDA
Set alert
At close
52-week range unavailable
- Open
- 9.00
- Prev close
- 9.20
- Mkt cap
- 40.64M
- Vol
- 314.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.90
- High
- 9.92
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 9.48
- Inst. own
- 44.22%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.18
- 200-d avg
- 10.54
- 1y target
- 0.00
News
3 weeks ago globenewswire.com
Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
ANN ARBOR, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Esperion, a company wholly-owned by ARCHIMED, today announced that it has entered into a settlement agreement with Renata Limited (along with an…
2 months ago globenewswire.com
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC, or other drug-related review matters. Remaining item relates to manufacturer…
5 months ago gurufocus.com
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection PR Newswire MUMBAI, India and NAP
8 months ago globenewswire.com
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
ANN ARBOR, Mich., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem). This agreement…
11 months ago globenewswire.com
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
WILMINGTON, Del., Dec. 02, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration…
1 year ago globenewswire.com
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy's Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040
ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy's Laboratories, Inc. and its affiliate Dr.…
1 year ago businesswire.com
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced a settlement agreement with Lupin Limited, resolving the patent infringement litigation…
1 year ago globenewswire.com
Supernus Announces Paragraph IV ANDA Filings for Qelbree®
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of…
1 year ago globenewswire.com
Esperion Reaches Settlement Agreement with ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
ANN ARBOR, Mich., May 12, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs…
1 year ago prnewswire.com
Hikma acquires Novugen's FDA-approved ANDA for trametinib
LONDON , April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application…
5 years ago globenewswire.com
Andina Acquisition Corp. III and Stryve Foods LLC Announce Shareholder Approval of the Business Combination
– Expected Closing Date of July 20, 2021 –
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Reminds VKIN, CLGX, VGAC, and ANDA Shareholders About Its Ongoing Investigations
NEW YORK, Feb. 25, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday morning saw 558 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
During the morning session on Friday, 389 stocks hit new 52-week highs.
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Investigates Andina Acquisition Corp. III
NEW YORK, Jan. 28, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Andina Acquisition Corp. III…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 92 companies achieved new highs for the year.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
This morning 301 companies reached new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 166 companies hit new 52-week highs.
5 years ago globenewswire.com
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Termination of Negotiations
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) announce that they have today mutually…
6 years ago globenewswire.com
Andina Acquisition Corp. III Announces Adjournment of the Extraordinary General Meeting of Shareholders for Approving an Extension of the Deadline Related to Consummating its Initial Business Combination
NEW YORK, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company's shareholders have voted to…
6 years ago globenewswire.com
Andina Acquisition Corp. III Announces Intention to Adjourn Extraordinary General Meeting of Shareholders for Approving an Extension of the Deadline Related to Consummating its Initial Business Combination
NEW YORK, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina” or the “Company”) today announced that the Company's board of directors has…
6 years ago globenewswire.com
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Provide Update on Status Towards Signing Business Combination Agreement
EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network in all Key European Markets EMMAC is…
6 years ago seekingalpha.com
Andina Acquisition Corp. III Rights And Warrants: Whether 3rd Time Will Be A Charm By October 31, 2020
Andina Acquisition Corp. III is a LATAM focused SPAC that will hold a special shareholders meeting on July 29, 2020 to extend its liquidation deadline by three months to October.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 154 stocks made new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 109 companies set new 52-week highs.
6 years ago thelincolnianonline.com
Embotelladora Andina SA ADR Series A (AKO.A) Scheduled to Post Quarterly Earnings on Tuesday
Embotelladora Andina SA ADR Series A (NYSE:AKO.A) will be announcing its earnings results after the market closes on Tuesday, April 28th. Investors interested in listening to the company’s conference…
6 years ago thelincolnianonline.com
Embotelladora Andina SA ADR Series A (NYSE:AKO.A) Stock Price Passes Below Two Hundred Day Moving Average of $13.79
Embotelladora Andina SA ADR Series A (NYSE:AKO.A) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $13.79 and…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday